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Abstract
Introduction: Previous studies in western countries have observed that women are less likely than men to receive
intensive care and mechanical ventilation (MV). We aimed to investigate whether the gender difference also exists
in Asian populations and in the provision of different types of MV including invasive (INV) and noninvasive
ventilation (NIV).
Methods: We analyzed all adult hospital patients between 2005 and 2007 in the claims data from 1,000,000
randomly selected people in the Taiwan National Health Insurance Research Database. NIV-only was defined as
patients receiving NIV as the only ventilator treatment during hospitalization. Gender difference was assessed using
multivariable analyses with/without considering a hospital cluster effect by generalized estimating equations
models. Subgroup analyses for gender difference in NIV use were performed using propensity score matching
method.
Results: Of the 128,327 patients enrolled, 53.8% were men, 9.2% received intensive care and 5.2% used MV. After
adjusting for potential confounders, women were less likely than men to receive intensive care (adjusted odds
ratio [aOR] 0.77, 95% confidence interval [CI] 0.73-0.82) and MV (aOR 0.84, 95% CI 0.78-0.91). Among MV patients,
6.8% received NIV-only; the proportion of which was higher in women than in men (8.6% vs. 5.7%, P < 0.001). After
controlling for confounders and a cluster effect, women remained more likely to receive NIV-only (aOR 1.61, 95% CI
1.32-1.96). Subgroup analyses showed that patients with underlying congestive heart failure (CHF) had the highest
difference in the provision of NIV-only (female-to-male aOR 2.76, 95% CI 1.38-5.53). A hospital cluster effect on the
gender difference in NIV use was found in patients with diseases other than chronic obstructive pulmonary disease
and CHF.
Conclusions: Gender differences existed not only in the provision but also in the types of MV. Further studies are
needed to understand why gender differences occur.
Introduction
Studies in western countries have shown that gender
differences exist in the process of care for critically ill
patients [1-3]. For example, women are found to be less
likely than men to receive intensive care [1,2] and inva-
sive treatments including mechanical ventilation (MV)
[1-3]. The suboptimal care might contribute to an
observed excess mortality in women [2]. Whether these
differences exist in Asian populations remains unknown.
Besides, the influence of gender on the provision of dif-
ferent types of MV, that is, invasive ventilation (INV)
and noninvasive ventilation (NIV), has not been
investigated.
NIV provides ventilator support via a nose/face mask
without using an invasive artificial airway for patients
with acute respiratory failure (ARF). The use of NIV has
been shown to reduce intubation and mortality in ARF
patients with acute pulmonary edema and underlying
chronic obstructive pulmonary disease (COPD) [4-7]. In
diseases other than COPD and acute pulmonary edema,
N I Vi sa l s oi n c r e a s i n g l yu s e dw i t hv a r i a b l es u c c e s sr a t e s
[8-12]. The utilization rates of NIV in patients with ARF
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But these data are underestimated because NIV is
increasingly initiated outside the ICU setting [14,15].
Women may be more likely to receive NIV if they are
less likely than men to receive invasive treatments such
as INV [1-3]. In addition, a higher perception of breath-
lessness in women [16,17] may increase the chance of
receiving an NIV trial for “shortness of breath” because
strict criteria are usually lacking in clinical practices [9].
In Taiwan, the National Health Insurance Research
Database (NHIRD) covers nearly all (99%) claims for its
population of more than 22 million. It has been used
extensively in various studies [18-20] and can provide
real world experiences of NIV use both outside and
i n s i d et h eI C U .T h e r e f o r e ,w ec o n d u c t e dt h i ss t u d y ,
based on the NHIRD, to analyze the nationwide utiliza-
tion of NIV in Taiwan and to assess whether gender dif-
ferences exist not only in the provision of intensive care
and MV but also in the provision of different types of
MV for patients with ARF. We hypothesized that
women are less likely than men to receive intensive care
and MV during hospitalization but receive more trials of
NIV for ARF and that the gender difference in NIV use
varies among subgroups of patients with underlying
COPD, congestive heart failure (CHF) and other
diseases.
Materials and methods
Database
In Taiwan, a compulsory and universal National Health
Insurance (NHI) program was initiated by the govern-
ment in 1995 [18]. With the exception of prison
inmates, all citizens are enrolled in the program.
Patients were drawn from the NHIRD, released for
research purposes by the National Health Research
Institute, Taipei, Taiwan. The NHIRD provided
encrypted patient identification numbers, sex, birthday,
dates of admission and discharge, medical institutions
providing the services, the ICD-9-CM (International
Classification of Diseases, Ninth Revision, Clinical Modi-
fication) codes of diagnoses (up to five) and procedures
(up to five), outcome at hospital discharge (recovered,
died or transferred out), order codes, and the fees
charged to patients.
Study sample
The study cohort was drawn from a subset of the
NHIRD, the Longitudinal Health Insurance Database of
2005 (LHID-2005) [18]. One million beneficiaries, repre-
senting about 5% of the Taiwanese population enrolled
in 2005, were selected using a simple random sampling
method from the NHIRD and included in the LHID-
2005 that contained all linked claims data of the cohort
from 2005 to 2007. There were no significant differences
in age and sex between the study cohort and the general
population [18]. The study period spanned from 1 Janu-
ary, 2005 to 31 December, 2007. All adult (≥ 18 years
old) patients were identified by linking through the hos-
pitalization claims data. Patients were excluded if they
were hospitalized for mental disorders (ICD-9-CM
codes 290-319) or had diagnoses related to complica-
tions of pregnancy, childbirth or the puerperium (ICD-
9-CM codes 630-679); the reasons for exclusion were
reduced likeliness of receiving non-psychiatric acute
medical treatment for the former and a lack of relevant
male-related codes for the latter. Patients were also
excluded if they were ventilator dependent in the
respiratory wards or received negative pressure or high
frequency oscillatory ventilation due to their chronic
respiratory failure and/or receipt of uncommon mode of
ventilation. To ensure the independence of observations,
only the first-episode admissions were included in the
analyses. Human Subjects Institutional Review Board
Approval and informed consent were not needed
because the study used an encrypted administrative
database.
Definition
Patients who received MV during acute care hospitaliza-
tions were designated as ARF [21]. INV-only was used
to define those receiving INV as the only ventilator
treatment and NIV-only was for those receiving only
NIV during the same hospitalization. Because we could
not verify the sequence, NIV/INV described those who
received both NIV and INV during the same hospitaliza-
tion. NIV was delivered using continuous positive airway
pressure and/or bilevel positive airway pressure ventila-
tion. The specific indications for MV or use of NIV
could not be determined because the database did not
provide such information. As claims reimbursement for
use of MV was based on a per day basis, not per hour
use, and only one claim can be filed for those receiving
b o t hI N Va n dN I Vo nt h es a m ed a y ,o n l yt h ec l a i mf o r
the higher-cost INV was made. For example, if one ARF
patient received NIV on day one but, due to NIV failure,
required INV from day two to five, and then when the
patient was weaned from INV, received NIV again on
day six for post-extubation respiratory distress, it would
show “NIV for two days” (i.e., day one and six) and
“INV for four days” (i.e., day two to five) on claims data.
The use of NIV on day two would not be eligible for
reimbursement.
Definitions of readmission, surgical conditions, and
hospital mortality have been described previously [19].
Measurements
Baseline characteristics of study subjects were examined,
including age, gender, medical/surgical conditions,
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nal hospitals with 250 to 500 beds, and district hospitals
with 20 to 249 beds), prevalence of selected comorbid
conditions (including COPD, CHF, cerebrovascular dis-
ease, and cancer), Charlson Comorbidity Index [22,23],
principal diagnoses, and occurrence of acute organ dys-
function (as a measure of disease severity) [19]. Out-
come measures included use and types of MV
(including INV-only, NIV-only, and NIV/INV), ICU
admission, duration of MV, length of stays, and hospital
m o r t a l i t y[ 1 9 ] .C O P Dw a sd e f i n e da sICD-9-CM codes
490 to 496 (excluding 493 for asthma). Definitions of
CHF, cerebrovascular disease, and cancer were based on
the Charlson Comorbidity Index [22,23], which is a
weighted summary measure of clinically important con-
comitant diseases that has been adapted for use with
ICD-9-CM coded administrative databases.
Statistics
Continuous variables were described as median (inter-
quartile range (IQR)) and compared by the Mann-Whit-
ney U test; discrete ones were expressed as counts or
percentages and analyzed by the chi-square test. To
examine the effects of gender on various outcomes, we
conducted multivariable logistic regression analyses
adjusting for the baseline covariates, including age, sur-
gical and selected comorbid conditions, Charlson
Comorbidity Index, hospital levels, principal diagnoses
and number of acute organ dysfunction. Additional cov-
a r i a t e ss u c ha ss t a t u so fM Vo ri n t e n s i v ec a r ew e r e
included as appropriate. Specifically, MV was included
as an additional covariate when modeling the gender
effect on the provision of intensive care and on hospital
mortality of patients requiring intensive care. Conver-
sely, intensive care status was included as an additional
covariate when modeling the gender effect on the provi-
sion of MV for all patients and that of different types of
MV for ARF patients as well as on hospital mortality of
ARF patients. Resource uses (including duration of MV
and length of stays) were compared using multivariable
linear regression models adjusting for the baseline cov-
ariates, with the inclusion of MV and intensive care sta-
tus as additional covariates when appropriate. Tolerance
level was calculated to assess multicollinearity, which
was defined as existing when the level was less than 0.1.
To further explore the effect of gender on the provi-
sion of different types of MV, we also applied the pro-
pensity score method [24-26] for ARF patients and for
subgroups with underlying COPD, CHF, and others.
Patients with COPD or CHF were selected because they
were associated with increased use of NIV [4,5]. The
propensity score method has been used to reduce bias
and increase precision of estimates in observational
research [24-26]. The propensity score, that is the
probability of being a female patient, was estimated by a
logistic regression model conditional on the baseline
covariates and intensive care status. For all ARF patients
and subgroups, men and women were matched one-to-
one by the propensity score using the greedy-matching
algorithm [26] and then analyzed in the logistic regres-
sion models to estimate the gender effect on the provi-
sion of NIV. Because hospitals tended to behave
differently and outcomes of patients within the same
hospitals were correlated, a hospital cluster effect might
be present [27]. Therefore, the gender effect on the pro-
vision of NIV was reanalyzed using logistic Generalized
Estimating Equations (GEE) models [27], specifying an
exchangeable structure of a working correlation matrix
to regress the correlated binary outcomes. The perfor-
mance of the propensity score model was assessed by
examining whether the baseline covariates of men and
women were balanced after matching. Data analysis was
performed using SPSS for Windows, version 17.0. (SPSS
I n c . ,C h i c a g o ,I L ,U S A )a n dS A Ss o f t w a r e ,v e r s i o n9 . 1
(SAS Institute, Inc., Cary, NC, USA). Statistical signifi-
cance was set at P < 0.05 (two-tailed).
Results
During the three-year study period, we identified
128,327 patients. Of them, 53.8% were men, 9.2% had
an ICU stay and 5.2% received MV (Figure 1). Charac-
t e r i s t i c so ft h es t u d yp o p u l a t i o na r es h o w ni nT a b l e1 .
Women were less likely than men to receive intensive
care (P < 0.001) and MV (P < 0.001). The differences
were consistent across all age groups except those aged
85 years or older (Figures 2a and 2b). After adjusting for
potential confounders (i.e., baseline and additional cov-
ariates as described in the Methods section), women
remained less likely than men to receive intensive care
(adjusted odds ratio (aOR) 0.77, 95% confidence interval
(CI) 0.73-0.82) and MV (aOR 0.84, 95% CI 0.78-0.91).
Distributions of different types of MV in ARF patients
are shown in Table 2. The age-and-gender-specific dis-
tribution of ARF patients receiving NIV is shown in Fig-
ures 2c and 2d. Among ARF patients, 6.8% received
NIV-only, of which a higher proportion was in women
than in men (Table 2).
Characteristics, resource use, and outcomes of ARF
patients stratified by gender and intensive care status
a r es h o w ni nT a b l e3 .A m o n gA R Fp a t i e n t s ,w o m e n
were older than men inside or outside the ICU, and
women being cared for inside the ICU had fewer surgi-
cal conditions. The distribution patterns of selected
comorbid conditions were different in ICU patients of
both genders but similar in those being cared for out-
side the ICU. But the distribution of principal diagnoses,
number of organ dysfunction, and hospital-level patterns
were comparable in both genders. Outcomes including
Shen et al. Critical Care 2011, 15:R174
http://ccforum.com/content/15/4/R174
Page 3 of 10the proportion of ICU admission (88.9% vs. 88.7%, P =
0.858), duration of MV, length of stays, and hospital
mortality were similar between men and women.
Among ARF patients receiving NIV (including NIV-only
and NIV/INV), duration of NIV was significantly longer
in women than in men (median three days, IQR one to
f i v ed a y sv s .t w od a y s ,I Q Ro n et of o u rd a y s ,
respectively: crude and adjusted P = 0.025 and 0.043,
respectively). The differences became insignificant when
durations of NIV in patients receiving NIV-only and
NIV/INV were calculated separately.
Among ARF patients, women were 63% more likely
than men to receive NIV-only after controlling for all
potential confounders (Table 4). These differences
Figure 1 Flow diagram of the study patients. The same excluded patient may appear in different categories. F, female; HFOV, high frequency
oscillatory ventilation; LHID, the Longitudinal Health Insurance Database of 2005; M, male; MV, mechanical ventilation; NHI, National Health
Insurance.
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Page 4 of 10changed little after using logistic GEE models, suggest-
ing a low cluster effect. The results based on analyses of
the propensity score matched pairs were similar (Table
4). The baseline characteristics of men and women were
balanced after matching (Table 5). In subgroup analyses,
t h eg e n d e rd i f f e r e n c ei nt h eu s eo fN I V - o n l yw a st h e
highest for ARF patients with CHF, followed by those
without COPD or CHF, but was insignificant for those
with COPD (Table 4). The cluster effect on the use of
NIV-only was unremarkable except in ARF patients
without COPD or CHF because the gender difference
became insignificant after using a logistic GEE model.
Discussion
In this study, we found that women were more likely
than men to receive NIV-only for ARF, especially those
with underlying CHF or diseases other than COPD. We
also confirmed the reports from western countries that
w o m e nw e r el e s sl i k e l yt h a nm e nt or e c e i v ei n t e n s i v e
care and MV [1-3]. Despite these differences, hospital
mortality in patients requiring MV or intensive care was
similar between men and women.
The finding that women were more likely to receive
NIV-only for ARF is consistent with prior reports [1-3].
Studies in Austria, Canada, Brazil, and the USA have
shown that women are less likely than men to receive
invasive treatments [1-3]. These findings suggest that
ethnic, cultural, and geographical factors do not seem to
contribute to the gender difference in the delivery of
NIV for ARF. However, the social context of gender dif-
ferences may influence the decision for initiating life-
supporting treatment [1,2], which could possibly lead to
ad i f f e r e n t i a lu s eo fN I V .A n dt h e r em a yb eam i xo f
biological and clinical explanations for it. For example, a
Table 1 Characteristics of the study population
(n = 128,327)
Variables Men
(n = 69,064)
Women
(n = 59,263)
Age, years 54 (39-70) 55 (41-71)
≥ 65 34.1 35.3
Surgical condition 43.8 47.3
Comorbidity
Charlson Comorbidity Index 0 (0-1) 0 (0-1)
COPD 4.7 2.1
Congestive heart failure 2.8 3.1
Cerebrovascular disease 7.3 6.2
Cancer 8.2 7.7
Principal diagnoses
Respiratory 10.8 8.5
Neurological 3.3 4.1
Cardiovascular 14.2 11.7
Digestive 16.4 10.8
Genitourinary 8.8 13.6
Metabolic/endocrine 2.6 3.8
Injury/poisoning 19.5 15.9
Others 24.5 31.6
No. of organ dysfunction
0 90.4 92.6
1 8.1 6.3
2+ 1.5 1.1
Mechanical ventilation 6.0 4.1
ICU admission 10.6 7.5
Hospital level
Medical center 34.0 35.4
Regional hospital 41.8 40.3
District hospital 24.2 24.3
Values are expressed as median (interquartile range) or percentages.
COPD, chronic obstructive pulmonary disease.
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Figure 2 Age-and-gender-specific proportional distributions of patients receiving (a) intensive care, (b) mechanical ventilation (MV),
(c) noninvasive and invasive ventilation (NIV/INV) and (d) NIV-only. Note: NIV-only was used to define those receiving NIV as the only
ventilator treatment and NIV/INV was for those receiving both NIV and INV during the same hospitalization. ARF, acute respiratory failure.
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Page 5 of 10higher use of NIV in women may reflect their increased
perception of breathlessness [16,17] and a lack of strict
criteria for NIV use in clinical practices [9]. Therefore,
women may receive NIV earlier, for longer, and perhaps
more frequently because they may report more symp-
toms of dyspnea even under similar respiratory condi-
tions [16,17]. Finally, the results of this study might also
imply that women could be more likely to succeed in
NIV treatment than men because the NIV-only group
was mostly made of patients with NIV success (plus do-
not-resuscitate patients who failed NIV without being
intubated) and the NIV/INV group was mostly those
with NIV failure (plus those who received a post-extu-
bation NIV). Nevertheless, because gender is not shown
to be associated with NIV failure [28], it might be more
likely that a higher rate of NIV use in women simply
reflects a gender bias in decision-making on NIV use
instead of a higher rate of NIV success.
There are other reasons that might also explain some
of the observed gender difference in NIV. First, misclas-
sification between INV-only and NIV/INV was likely. In
unselected patients with ARF receiving NIV, the
reported intubation rates after a failed trial range from
10% to 60%; among them, 60% to 100% occur within 24
hours [8-10,13,29-33]. Therefore, the utilization rate of
NIV in this study is likely to be underestimated.
Because of the limitation in the Taiwan’s NHI reimbur-
sement policy (see methods section), the NHIRD tended
to capture claims of patients receiving longer-duration
NIV and misclassify those using INV-only and NIV/
INV (i.e., to overestimate INV-only and underestimate
NIV/INV). Since duration of NIV did not differ signifi-
cantly between men and women receiving NIV/INV,
misclassification would be similar for both genders and
hence less likely to cause the observed difference.
Besides, this bias cannot explain the difference observed
in the provision of NIV-only. Second, some potential
confounders could not be controlled in this study. For
example, differential sex distributions have been
reported in many aspects including the severity of acute
illnesses [1], the occurrence of post-extubation stridor
[34], the preference of advance directives (such as do-
not-resuscitate or do-not-intubate orders) [35] and the
population prevalence and incidence of some acute ill-
nesses [36,37] or chronic comorbidities [38,39]; all of
which have been shown to influence the outcome of,
and hence the decision-making for, an NIV trial [28,39].
For this reason, we did a sub-analysis in propensity-
score-matched pairs with underlying CHF and found
that women were still more than twice as likely as men
to receive NIV-only. And finally, a hospital cluster effect
may also explain some of the observed difference in
subgroups such as ARF patients with diseases other
than COPD or CHF.
Table 2 Distributions of different types of mechanical
ventilation in patients with acute respiratory failure
Variables No INV-only,
%
NIV-only,
%
NIV/INV,
%
P
Value
Total 6,621 84.6 6.8 8.6
Sex < 0.001
Men 4,177 85.9 5.7 8.4
Women 2,444 82.4 8.6 9.0
Age < 0.001
< 65 years 2,917 88.9 4.8 6.3
≥ 65 years 3,704 81.3 8.3 10.4
Surgical condition < 0.001
Yes 3,594 87.5 3.5 9.0
No 3,027 81.2 10.6 8.1
Charlson
Comorbidity index
< 0.001
0 2,158 88.3 4.4 7.3
1 2,076 83.9 7.0 9.1
2 1,258 81.4 9.6 9.0
3+ 1,129 82.4 7.7 9.9
Comorbid
conditions
COPD < 0.001
Yes 533 66.2 16.7 17.1
No 6088 86.2 5.9 7.9
Congestive heart
failure
< 0.001
Yes 573 74.9 12.2 12.9
No 6,048 85.5 6.3 8.2
Cerebrovascular
disease
< 0.001
Yes 1,118 89.6 3.2 7.2
No 5,503 83.6 7.5 8.9
Cancer 0.001
Yes 946 82.2 9.5 8.2
No 5,675 85.0 6.3 8.7
Principal diagnoses < 0.001
Respiratory 1,395 76.3 12.4 11.3
Non-respiratory 5,220 86.9 5.2 7.9
No. of organ
dysfunction
0.011
1 5,173 83.8 7.5 8.7
2 1,198 86.9 4.5 8.6
3+ 250 90.4 2.4 7.2
ICU admission < 0.001
Yes 5,882 87.5 3.1 9.5
No 739 61.8 36.3 1.9
Hospital level < 0.001
Medical center 2,861 81.0 7.7 11.4
Regional
hospital
2,802 86.3 6.2 7.5
District hospital 958 90.6 5.6 3.8
COPD, chronic obstructive pulmonary disease; INV-only, use of invasive
ventilation (INV) as the only ventilator treatment; NIV-only, use of noninvasive
ventilation (NIV) as the only ventilator treatment; NIV/INV, use of both NIV and
INV before or after each other.
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Page 6 of 10The reasons that the gender difference in the provi-
sion of NIV was not found in patients with COPD are
unclear. As COPD is the most well-established disease
benefited from NIV [4,5], the gender difference may be
less likely to occur. However, because women are at risk
of under-diagnosis, and hence being under-coded, of
COPD [40], the results could be either over- or under-
estimated. For example, failure to code for COPD would
hinder the adjustment for women and thereby bias the
observed association between women and NIV away
from the null. On the other hand, failure to diagnose
COPD could theoretically result in under-utilization of
NIV in women. This may also explain the null finding
in ARF patients with COPD.
Our study provides the first nationwide population-
based data on the utilization rate of NIV (including NIV-
only and NIV/INV) both outside and inside the ICU in
Taiwan. The utilization rate was slightly lower than that
in developed countries (15.4% vs. 16% to 24%, respec-
tively) [12-14,29,41]. The reported rates in developed
countries are also likely to be under-estimated by includ-
ing only ICU patients [12-14,30,41]; and the under-esti-
mation may become more significant over time due to
increased successful use of NIV outside the ICU
[14,42,43]. For example, in a regional survey of 82 acute
care hospitals in the USA, 20% of ARF patients received
NIV, of which 45% of the treatment was initiated outside
the ICU [42]. In this study, 27.7% of patients receiving
NIV were cared for only outside the ICU.
The effect of gender on the outcome of patients
requiring intensive care or MV remains debatable
[1,2,31,44-46]. Although a higher risk of death in
women requiring intensive care or MV has been found
in some studies [2,44,45], it is not confirmed by others
[1,31,46]. Our study did not find the gender effect on
the outcomes of these patients despite the observed dif-
ference in the process of care. This finding is consistent
with a prior report [1] showing that a more invasive
therapeutic approach in men does not translate to a bet-
ter outcome.
Table 3 Characteristics, resource use and outcomes of patients with acute respiratory failure by gender and intensive
care status (n = 6,621)
Variables With intensive care Without intensive care
Men (n = 3,713) Women (n = 2,169) P Value Men (n = 464) Women (n = 275) P Value
Age, years 65 (49-77) 71 (56-80) < 0.001 70 (52-79) 72 (57-82) 0.032
≥ 65 50.9 62.9 < 0.001 59.9 62.2 0.542
Surgical condition 57.7 54.5 0.018 36.0 36.7 0.841
Cormorbidity
Charlson Comorbidity Index 1 (0-2) 1 (0-2) 0.080 1 (0-2) 1 (1-2) 0.132
COPD 8.9 4.4 < 0.001 16.2 12.0 0.121
Congestive heart failure 7.3 11.2 < 0.001 7.3 9.1 0.393
Cerebrovascular disease 17.1 19.3 0.034 8.0 10.5 0.236
Cancer 14.6 11.0 < 0.001 22.2 23.3 0.736
Principal diagnoses 0.664 0.734
Respiratory 19.8 19.3 33.3 32.1
Non-respiratory 80.2 80.7 66.7 67.9
Number of organ dysfunction 1 (1-1) 1 (1-1) 0.779 1 (1-1) 1 (1-1) 0.284
Hospital level 0.085 0.905
Medical center 41.4 41.4 58.0 56.7
Regional hospital 45.2 43.2 24.4 25.8
District hospital 13.4 15.4 17.7 17.5
Types of mechanical ventilation < 0.001 0.001
NIV-only 2.3 4.3 32.5 42.5
NIV/INV 9.3 9.7 1.1 3.3
INV-only 88.3 86.0 66.4 54.2
Resource use
Duration of MV 3 (1-8) 3 (1-8) 0.831 1 (1-4) 2 (1-4) 0.954
ICU LOS, days 4 (2-9) 4 (2-9) 0.860 0 0 -
Hospital LOS, days 17 (8-30) 16 (8-29) 0.863 10 (5-19) 11 (6-19) 0.842
Hospital mortality 27.2 28.0 0.321 34.3 28.7 0.098
Values are expressed as median (interquartile range) or percentages.
COPD, chronic obstructive pulmonary disease; INV-only, use of invasive ventilation as the only ventilator treatment; LOS, length of stay; MV, mechanical
ventilation; NIV-only, use of noninvasive ventilation as the only ventilator treatment; NIV/INV, use of both NIV and INV before or after each other.
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Page 7 of 10Table 4 Female-to-male odds of receiving different types of mechanical ventilation (MV) among patients with acute
respiratory failure (ARF)
a
Types of MV Conventional
method
b
Propensity score method
c
All ARF patients
(M/F = 4177/2444)
ARF patients
(M/F = 2390/2390)
ARF patients with
COPD
(M/F = 126/126)
ARF patients with
CHF
(M/F = 217/217)
Other ARF
patients
d
(M/F = 2037/2037)
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Without GEE
modeling
a
NIV-only 1.63 (1.30-2.05) 1.50 (1.20-1.88) 1.08 (0.56-2.09) 2.76 (1.47-5.20) 1.43 (1.10-1.85)
NIV/INV 1.10 (0.91-1.32) 1.05 (0.86-1.28) 0.97 (0.50-1.86) 1.06 (0.58-1.92) 1.07 (0.85-1.35)
INV-only 0.76 (0.66-0.89) 0.80 (0.68-0.93) 0.97 (0.58-1.62) 0.55 (0.35-0.86) 0.81 (0.68-0.97)
With GEE modeling
a
NIV-only 1.61 (1.32-1.96) 1.58 (1.15-2.15) 1.07 (0.55-2.11) 2.76 (1.38-5.53) 1.43 (0.97-2.11)
NIV/INV 1.11 (0.96-1.29) 1.07 (0.85-1.35) 1.01 (0.48-2.14) 1.08 (0.57-2.03) 1.09 (0.82-1.45)
INV-only 0.75 (0.64-0.88) 0.77 (0.61-0.95) 0.95 (0.54-1.66) 0.55 (0.33-0.93) 0.80 (0.60-1.06)
a Multivariable logistic regression models with and without considering the cluster effect of hospitals using GEE models.
b Conventional multivariable logistic regression adjusting for age, surgical and selected comorbid conditions, Charlson Comorbidity index, hospital levels,
principal diagnoses, number of acute organ dysfunction, and intensive care status.
c Men and women were matched one-to-one by the propensity score and then analyzed in the logistic regression models.
d Other ARF patients included those without underlying COPD or CHF.
aOR, adjusted odds ratio; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; GEE, generalized estimating
equations; INV, invasive ventilation; INV-only, use of INV as the only ventilator treatment; NIV/INV, use of both NIV and INV before or after each other; NIV,
noninvasive ventilation; NIV-only, use of NIV as the only ventilator treatment.
Table 5 Balances between men and women after one-to-one matching by the propensity score*
ARF patients ARF patients with COPD ARF patients with CHF Other ARF patients
Women
(n = 2390)
Men
(n = 2390)
Women
(n = 126)
Men
(n = 126)
Women
(n = 217)
Men
(n = 217)
Women
(n = 2037)
Men
(n = 2037)
Age, years 70 (55-80) 71 (56-79) 78 (72-85) 77 (70-83) 76 (70-82) 77 (68-82) 69 (53-79) 69 (53-78)
Surgical condition 52.9 53.6 22.2 21.4 28.6 33.2 57.2 57.8
Comorbidity
Charlson Comorbid Index 1 (0-2) 1 (0-2) 2 (1-2) 1 (1-2) 2 (1-3) 2 (1-3) 1 (0-2) 1 (0-2)
COPD 5.4 5.2 - - 11.5 12.9 - -
Congestive heart failure 10.5 10.0 19.0 20.6 - - - -
Cerebrovascular disease 18.2 18.9 13.5 11.9 7.8 5.5 19.6 21.1
Cancer 12.9 12.9 4.0 4.8 4.1 5.1 14.5 14.5
Principal diagnoses
Respiratory 20.9 20.3 65.1 65.9 32.3 30.9 17.4 18.0
Neurological 1.7 1.6 8.7 10.3 0 0 1.8 1.9
Cardiovascular 24.7 24.5 12.7 10.3 48.8 49.3 22.4 22.4
Digestive 8.5 8.6 4.8 5.6 4.1 3.2 9.1 9.3
Genitourinary 2.8 2.5 4.0 3.2 2.3 3.2 2.8 2.2
Metabolic/endocrine 1.9 1.7 0 0 0 0 2.2. 1.7
Injury/poisoning 15.2 15.6 4.0 4.0 2.3 3.2 17.4 17.4
Others 24.4 25.3 8.7 10.3 10.1 10.1 26.8 27.0
No. of organ dysfunction 1(1-1) 1(1-1) 1(1-1) 1(1-1) 1(1-1) 1(1-1) 1(0-1) 1(0-1)
Intensive care unit admission 88.7 88.7 74.6 73.8 90.8 89.4 89.4 89.7
Hospital level
Medical center 43.4 43.5 32.5 29.4 31.3 35.5 45.4 45.4
Regional hospital 41.2 41.1 42.9 47.6 47.0 47.0 40.4 40.9
District hospital 15.4 15.4 24.6 23.0 21.7 17.5 14.3 13.7
* Categorical variables are tested by the McNemar’s test; continuous variables by the Wilcoxon Signed-rank test. All P values > 0.05.
Values are expressed as median (interquartile range) or percentages.
ARF, acute respiratory failure; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; Other ARF, diseases other than COPD or CHF.
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d i f f e r e n c ei nN I Vu s em a yp r o v i d ep o l i c yi m p l i c a t i o n s
for best practice provision across hospitals. The cluster
effect implies that clinicians are not using standard cri-
teria to start NIV based on evidence from guidelines
[5,12]. Non-adherence to guidelines is also present in
situations eligible for NIV, leading to its underuse
[12,47]. For example, one retrospective study showed
that nearly two thirds of ICU patients with exacerbation
of COPD or CHF did not receive an NIV trial despite
meeting eligibility criteria [47]. However, because the
indication for NIV could not be determined in this
study, we do not know whether the use of NIV for ARF
is appropriate to the guidelines.
Several other limitations deserve comments. First,
the administrative databases are subject to possible
under-coding and over-coding errors. The definitions
of diagnoses relied solely on diagnostic codes, but the
accuracy of which could not be verified. Second, infor-
mation on primary causes of ARF, indications/mode/
settings and effectiveness of NIV use, and types of ven-
tilators was not available. Third, hospital mortality
might be under-estimated for the inability to verify
through linkage to death certificate. And finally, since
only five diagnostic codes were available, some related
diagnoses could have been missed. But these biases are
toward the null. Nevertheless, our study is strength-
ened by the large number of patients retrieved from a
nationwide population-based dataset, which can
provide an unbiased selection and enhance its
generalizability.
Conclusions
This study suggests that gender difference not only
existed in the provision of intensive care and MV, but
also in the use of NIV in Taiwan. The subgroup ana-
lyses indicate that the gender differences in NIV use
were heterogeneous and related to the underlying dis-
eases. Further research is needed to explore why gender
differences exist, especially whether and how gender-
biased decision-making affects the use of NIV.
Key messages
￿ Studies in western countries have shown that gen-
der differences exist in the process of care for criti-
cally ill patients.
￿ Our findings confirm the reports from western
countries that women were less likely than men to
receive intensive care and mechanical ventilation.
￿ Moreover, we found that women were more likely
than men to receive NIV-only for acute respiratory
failure, especially those with underlying heart failure.
￿ The finding of a higher NIV use in women may
reflect a higher perception for dyspnea and their
lower tendency to receive invasive treatments than
men as well as a lack of strict criteria for NIV use in
clinical practices.
￿ Further research is needed to understand why the
gender difference occurs, especially whether and
how gender-biased decision-making affects the use
of NIV.
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